Background: Polyglutamine expansion is responsible for several neurodegenerative disorders, among which Huntington disease is the most well-known. Studies in the yeast model demonstrated that both aggregation and toxicity of a huntingtin (htt) protein with an expanded polyglutamine region strictly depend on the presence of the prion form of Rnq1 protein ([PIN + ]), which has a glutamine/asparagine-rich domain.
Introduction
Expansion of polyglutamine (polyQ) stretches in nine otherwise unrelated human proteins causes neurodegenerative diseases accompanied by deposition of amyloid protein aggregates formed by these proteins. One of the most common polyQ disorders, Huntington disease, is caused by exon I IT15 mutations that increase the number of CAG triplets, coding for Q in the huntingtin (htt) protein and develops at a probability proportional to the number of these repeats. Htt with expanded N-terminal polyQ can aggregate and form insoluble intracellular inclusions which appear mostly in the nucleus and, to a lesser extent, in the cytoplasm [1] . Despite extensive studies, the molecular bases of polyQ diseases are still unclear, though it was shown that the toxic effect of expanded polyQ proteins is related to interference with the normal function of cellular proteins thus affecting various cellular processes. Indeed, pathological htt impairs gene transcription, ubiquitin-proteasome system, causes mitochondrial dysfunction, dysregulation of Ca 2+ homeostasis, impairment of axonal transport and genotoxic stress (see [2] for a review).
PolyQ disorders and Huntington disease in particular are especially attractive for modeling in yeast, because, similar to them, yeast prions rely on domains enriched with Q. As in humans, in yeast aggregation and toxicity of htt increase with polyQ length and targeting of mutant htt into the nucleus alters transcription of a subset of genes and decreases cell viability [3] . Besides glutamine, prion domains of yeast proteins are also rich in asparagine residues (N). Importantly, expanded polyN stretches are similar to polyQ in their propensity to form aggregates in yeast and were also used to model polyQ disorders since nuclear localization of such proteins also causes transcriptional abnormalities and cell death [4] . Cytoplasmically expressed htt with an expanded polyQ region was also shown to be toxic, although its toxicity and aggregation depended on the presence of [PIN + ], the prion form of the QN-rich protein Rnq1, known to facilitate the de novo appearance of other yeast prions [5, 6] . Besides, toxicity of expanded htt in yeast cytoplasm is modulated by the sequences flanking the polyQ stretch [7] . Use of the yeast model revealed that polyQ aggregation results in endocytosis impairment, suggesting that this is one of the causes of cellular toxicity [8] .
Another reason for toxicity of proteins with expanded polyQ can be interactions with certain genome-encoded Q/N-rich proteins whose lack or overproduction can cause or abolish polyQ toxicity [6] .
Previously we have shown that aggregation of proteins with expanded polyQ, including mutant htt, in the cytoplasm of yeast cells caused polymerization of chromosomally-encoded Q/N-rich proteins [9] . Since there are a large number of proteins with long Q/N-rich stretches in both humans and yeast [10, 11] , it is likely that at least some of them would efficiently polymerize in response to the accumulation of polyQ amyloids, which may cause depletion of their functional soluble form and, as a result, cell death, if these proteins are essential. Here, we used the yeast model of Huntington disease to confirm this suggestion for the essential Q/N-rich protein, translation termination factor eRF3, which is usually designated in yeast as Sup35. [5, 6] . This was shown for htt with a polyQ stretch consisting of 103 Q (103Q) fused to the green fluorescent protein (GFP), which allows monitoring of 103Q-GFP aggregation microscopically, as distinct fluorescent foci. However, as we have shown previously, polyQ proteins could also form SDS-insoluble polymers in cells lacking these prions ( ] transformants of the strain 74-D694 with the multicopy p103Q-GFP plasmid were grown in liquid SC-Ura glucose-containing medium (Glc), then in the same selective raffinose-containing (Raf) and galactose-containing (Gal) media, as described in Materials and Methods, and incubated in the latter medium for 1, 2, 4, 6 and 9 h. (B) 1:3, 1:9, 1:27 and 1:81, dilutions of the sample taken after 9 h incubation. Polymers of 103Q-GFP were visualized by SDD-AGE. Blots were stained with the monoclonal anti-GFP antibody. (Fig. 4 ) in which both 103Q-GFP and Sup35 polymerized most efficiently ( Fig. 1 and 3) . Expression of the non-aggregating form of Sup35, which lacked the NM region (Sup35C), instead of the full-length protein, alleviated the toxic effect of 103Q-GFP in [PIN + ] cells and completely abolished it in [pin 2 ] cells (Fig. 4) . This suggested that Q103-GFP toxicity was due to depletion of soluble Sup35. Alternatively, it was possible that this effect was due to the influence of Sup35C on the levels of 103Q-GFP and Rnq1 polymers or due to effects of Sup35C on cell growth irrespective of the presence of these polymers. However since neither the levels nor size distributions of Rnq1 and 103Q-GFP polymers did not depend on the presence of the NM region in Sup35 ( ] with the multicopy p103Q-GFP or p25Q-GFP plasmids were grown as described in Materials and Methods with incubation in SC-Ura Gal medium for indicated time. Equal amounts of total protein (confirmed by staining the same membranes by Ponceau S, a non-specific protein stain) from each lysate were serially diluted in four-fold increments and applied to a nitrocellulose membrane. Blots were probed with the monoclonal anti-GFP antibody. doi:10.1371/journal.pone.0029832.g002 ] transformants with the p103Q-GFP plasmid were grown as described in Materials and Methods. After incubation in SC-Ura Gal medium for 9 h, cells were harvested and their lysates were used to analyze the amount of SDS-insoluble polymers of Sup35. (B) The levels of Sup35 monomer, SDS-PAGE analysis. Lysates were obtained from cells grown as described above. The samples were not boiled before loading onto the gel which only allowed SDS-soluble Sup35 to enter the gel [34] . Lower bands represent a Sup35 degradation product, characteristic of the non-prion/amyloid form of Sup35 [36] It is known that Sup35 prion aggregates may include different proteins able to interact with Sup35 [13, 14] in an SDS-sensitive manner. Sequestration of Sup45 (translation termination factor eRF1) into Sup35 prion aggregates can cause growth inhibition, and this defect can be alleviated by increasing Sup45 levels [15, 16] . Similarly to prion polymers of Sup35, non-prion polymers of this protein also contained Sup45, since centrifugation of lysates of [PIN + ] cells overproducing 103Q-GFP revealed appearance of Sup45 in the pellet fraction and a related 2-fold decrease of the levels of its soluble form, while in cells expressing non-aggregating 25Q-GFP Sup45 was primarily soluble (Fig. 5) . Introduction of a centromeric plasmid with SUP45 into [PIN + ] and [pin 2 ] cells expressing 103Q-GFP partially alleviated the toxic effects of 103Q-GFP (Fig. 6 ), which could be related to increased levels of soluble Sup45 (Fig. 5 ).
Results
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Discussion
Earlier it was reported that in contrast to [ ] cells. Finally, the toxicity of 103Q-GFP also depended on sequestration of Sup45 into Sup35 aggregates. The critical role of Sup35 in 103Q-GFP toxicity may seem surprising, since it is just one of more than a hundred of yeast Q/N-rich proteins, many of which are essential [10, 11] . However, it is necessary to stress that among essential Q/N-rich proteins, Sup35 has one of the highest expression levels [17] and that its polymerization caused aggregation and inactivation of another essential protein, Sup45. It is also necessary to take into account that 103Q-GFP may seed polymerization of different cellular Q/ N-rich proteins with varying efficiency and Sup35 may be among ] transformants of the 74-D694 strain (SUP35) or its 74-D694 DS35 derivative disrupted for chromosomal SUP35 and carrying SUP35-C on a centromeric plasmid (SUP35-C), both expressing either 103Q-GFP or 25Q-GFP, were grown at 30uC in liquid SC-Ura medium with glucose resuspended in the same medium but with raffinose instead of glucose and after 12 h incubation, cell suspensions were diluted to an OD 600 of 1.0, and then spotted onto SC-Ura plates with galactose as a sole carbon source (Gal) and incubated for 4 days. ] cells overproducing Sup35 [14] . Notably sequestration of the translation termination factors could not completely account for 103Q-GFP toxicity, because overproduction of the 103Q-GFP protein also manifested toxicity in the [PIN + ] strain expressing Sup35C which is unable to form SDS-insoluble polymers.
At present it is believed that microscopically visible protein aggregates, which are frequently associated with neurodegenerative diseases, in fact play a cytoprotective role, while toxicity of amyloidogenic proteins is related to accumulation of their oligomeric species [18, 19] . In this work we observed that in ] with plasmids expressing 103Q-GFP or 25Q-GFP were grown as described in Materials and Methods. After incubation in SC-Ura Gal medium for 9 h, cells were harvested. Cell lysates were fractionated by centrifugation and fractions were analyzed by Western blotting: staining with either anti-Sup35NM (Sup35) or anti-Sup45 (Sup45) polyclonal antibodies. The lower bands in the Sup35 image represent a degradation product (see legend to Fig. 3) ; the lower bands in the Sup45 image are nonspecific protein staining [20] . T, total protein; S, soluble fraction (1:2 and 1:4, dilutions); P, pellet. CEN-SUP45, the centromeric plasmid pRS315-SUP45; empty vector, pRS315. Quantitative data on Sup45 levels obtained by densitometric analysis demonstrated that expression of Q103-GFP caused an approximately 2-fold depletion of the soluble fraction of Sup45, with the remaining portion of the protein being relocated into the pellet fraction. Presence of pRS315-SUP45 caused an approximately 4-fold increase in the level of soluble Sup45 in Q103-GFP expressing cells as compared with the same cells with an empty vector. Notably, depletion of Sup35 and Sup45 induced by 103Q-GFP may impair not only translation termination, but also other processes, since both termination factors have essential nontranslational functions, being important for cytoskeleton organization, cytokinesis, cell cycle regulation [20, 21] and probably for other processes [22, 23] , such as coupling termination and initiation steps of translation [24, 25] and regulation of mRNA deadenylation and decay [26] , which are mediated by interaction of the N-terminal region of Sup35 with poly(A) + binding protein PABP. Modeling of htt toxicity in yeast showed that polymerization of expanded polyQ caused polymerization of cellular Q/Nrich proteins and related sequestration of other proteins able to interact with these Q/N-rich proteins. If such proteins are essential, depletion of their soluble and functional form may be deleterious to the cell. Thus, though there may be different sources of polyQ toxicity in eukaryotes, this mechanism can explain why a wide variety of different processes, including translation, were found to be altered in the yeast model of Huntington disease [27] . It is also likely that a similar mechanism underlies depletion of transcription factors possessing polyQ repeats in mammalian cells expressing proteins with expanded polyQ [28] [29] [30] . [12] were used. The plasmids used in this study are described in Table 1 . Yeast were grown at 30uC in rich (YPD, 1% yeast extract, 2% peptone, 2% glucose) or synthetic (SC, 0.67% yeast nitrogen base, 2% glucose supplemented with the required amino acids) media. To induce the synthesis of 103Q-GFP and 25Q-GFP chimeric proteins, cell cultures with corresponding plasmids were transferred to liquid selective media with 2% raffinose as a sole carbon source and grown until mid-log phase. Then cultures were transferred to of the same medium with galactose instead of raffinose and cells were grown for the indicated time. The final concentration of galactose in the medium was 2%.
Materials and Methods
Plasmids, strains and growth conditions
Preparation of yeast cell lysates
Yeast cultures grown in liquid selective media were harvested, washed in water and lyzed by beating with glass beads (Bullet Blender, Next Advance) in buffer A: 30 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM dithiothreitol and 1% Triton X-100. To prevent proteolytic degradation, 10 mM phenylmethylsulfonyl fluoride and Complete TM protease inhibitor cocktail (Roche Applied Science) were added. Cell debris was removed by centrifugation at 1500 g for 4 min.
Centrifugation
To separate Sup35 and Sup45 polymer and monomer fractions, 500 ml of yeast cell lysates were centrifuged at 100,000 g (48,000 rpm in a Ti75 rotor, Beckman Optima TL ultracentrifuge) for 1 h at 4uC.
Electrophoresis and blotting
These were performed as described previously [32] [33] [34] . Protein loads were equalized for each gel. For analysis of amyloid polymers we used horizontal 1.8% agarose gels in the TrisAcetate-EDTA (TAE) buffer with 0.1% SDS. Lysates were incubated in the sample buffer (0.56 TAE, 2% SDS, 5% glycerol and 0.05% Bromophenol Blue) for 5 min at 37uC. After the electrophoresis, proteins were transferred from gels to nitrocellulose membrane sheets (ThermoScientific, USA) by vacuumassisted capillary blotting for 5 h (agarose gels), or electrophoretically (polyacrylamide gels). Bound antibody was detected using the ECL West Dura system (Thermo Scientific). It should be noted that detergents (SDS or sarcosyl) in non-boiled samples increase degradation of Sup35 monomers. This can result in the absence of Sup35 monomer bands in SDD-AGE gels. Rabbit polyclonal antibodies against Sup35 and Sup45 were used. Anti-GFP monoclonal antibody was obtained from Rusbiolink (Russia). Estimation of relative amount of 103Q-GFP or 25Q-GFP in lysates was performed as described in [35] , with minor modifications. Densitometry measurements were performed using ImageJ software. ] carrying the URA3 p25Q-GFP (25Q) or p103Q-GFP (103Q) plasmids was transformed with either the LEU2 plasmid pUKC815-L (encodes a PGK1-lacZ gene fusion) or pUKC817-L (encodes the same gene fusion but with in frame UAA at the junction of the PGK1 and lacZ genes) (Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, Nierras CP, Cox BS, Ter-Avanesyan MD, Tuite MF (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14: 4365-4373). Transformants were grown consecutively in liquid glucose-, raffinose-and galactose-containing media selective for the plasmids, and after a 9 h incubation in SC-Ura -Leu Gal medium appropriate aliquots of yeast culture were taken and b-galactosidase activity was assayed. All data represent an average of at least three independent experiments. The nonsense readthrough levels were determined as ratio of bgalactosidase activities in the cells transformed with the plasmid pUKC817-L to that of the transformant with pUKC815-L. (TIF) Table 1 . Plasmids used in this study.
Supporting Information
Plasmid
Characteristics Reference pRS315 Centromeric LEU2 vector [37] pRS315-SUP45 Same as pRS315, but with SUP45 [21] pRS315-SUP35C Same as pRS315, but with SUP35-C [22] p103Q-GFP Multicopy URA3 pYES2 plasmid, encoding fusion of 103Q with GFP under the control of GAL1 promoter [5] p25Q-GFP Multicopy URA3 pYES2 plasmid, encoding fusion of 25Q with GFP under the control of GAL1 promoter [5] doi:10.1371/journal.pone.0029832.t001 Figure S2 The levels of Rnq1 and 103Q-GFP polymers do not depend on the presence of the Sup35 NM region. ] strain (SUP35) or its 74-D694 DS35 derivative disrupted for the chromosomal SUP35 gene and carrying SUP35-C on a centromeric plasmid (SUP35-C), both expressing 103Q-GFP, were grown as described in Materials and Methods. After incubation in SC-Ura Gal medium for 9 h cells were harvested and their lysates were used to estimate the amount of Q103-GFP and Rnq1 SDS-insoluble polymers by SDD-AGE analysis. Blots were stained with anti-Rnq1 polyclonal antibody (A) or anti-GFP monoclonal antibody (B). 
